Nuclear Imaging Devices Market by Type and Application - Global Industry Analysis & Forecast to 2027

Published On : April 2021 Pages : 166 Category: Pharma & Healthcare Report Code : HC0417219

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Nuclear Imaging Devices Market By Type (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Nuclear Imaging Devices Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Nuclear Imaging Devices imaging uses small amounts of radioactive materials called radiotracers that are typically injected into the bloodstream, inhaled or swallowed.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Nuclear Imaging Devices Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Siemens Healthineers (Germany)
  • GE Healthcare (US)
  • Koninklijke Philips (Netherlands)
  • Digirad Corporation (US)
  • Neusoft Medical Systems Co., Ltd (US)
  • Canon Medical Systems Corporation (Japan)
  • SurgicEye GmbH (Germany)
  • DDD-Diagnostic A/S (Denmark)
  • CMR Naviscan Corporation (US)
  • Mediso Ltd. (Hungary)
  • Shimadzu Corporation (Japan)

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Nuclear Imaging Devices Market , By Type, Estimates and Forecast, 2017-2027 ($Million)

o    SPECT (Hybrid SPECT, Standalone SPECT)

o    Hybrid PET

o    Planar Scintigraphy

·         Nuclear Imaging Devices Market , By Application, Estimates and Forecast, 2017-2027 ($Million)

o    Oncology

o    Cardiology

o    Neurology

·         Nuclear Imaging Devices Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    Siemens Healthineers (Germany)

o    GE Healthcare (US)

o    Koninklijke Philips (Netherlands)

o    Digirad Corporation (US)

o    Neusoft Medical Systems Co., Ltd (US)

o    Canon Medical Systems Corporation (Japan)

o    SurgicEye GmbH (Germany)

o    DDD-Diagnostic A/S (Denmark)

o    CMR Naviscan Corporation (US)

o    Mediso Ltd. (Hungary)

o    Shimadzu Corporation (Japan)

·         Nuclear Imaging Devices Market , By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Nuclear Imaging Devices Market , By Country

o    U.S. Nuclear Imaging Devices Market

o    Canada Nuclear Imaging Devices Market

o    Mexico Nuclear Imaging Devices Market

o    Europe

§  Europe Nuclear Imaging Devices Market , By Country

o    UK Nuclear Imaging Devices Market

o    Germany Nuclear Imaging Devices Market

o    France Nuclear Imaging Devices Market

o    Russia Nuclear Imaging Devices Market

o    Italy Nuclear Imaging Devices Market

o    Rest of Europe Nuclear Imaging Devices Market

o    Asia-Pacific

§  Asia-Pacific Nuclear Imaging Devices Market , By Country

o    China Nuclear Imaging Devices Market

o    Japan Nuclear Imaging Devices Market

o    South Korea Nuclear Imaging Devices Market

o    India Nuclear Imaging Devices Market

o    Southeast Asia Nuclear Imaging Devices Market

o    Rest of Asia-Pacific Nuclear Imaging Devices Market

o    South America

§  South America Nuclear Imaging Devices Market

o    Brazil Nuclear Imaging Devices Market

o    Argentina Nuclear Imaging Devices Market

o    Columbia Nuclear Imaging Devices Market

o    Rest of South America Nuclear Imaging Devices Market

o    Middle East and Africa

§  Middle East and Africa Nuclear Imaging Devices Market

o    Saudi Arabia Nuclear Imaging Devices Market

o    UAE Nuclear Imaging Devices Market

o    Egypt Nuclear Imaging Devices Market

o    Nigeria Nuclear Imaging Devices Market

o    South Africa Nuclear Imaging Devices Market

o    Turkey Nuclear Imaging Devices Market

o    Rest of MEA Nuclear Imaging Devices Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Nuclear Imaging Devices  Market, By Type

5.1.     Introduction

5.2.     Global Nuclear Imaging Devices  Revenue and Market Share by Type (2017-2021)

5.2.1.  Global Nuclear Imaging Devices  Revenue and Revenue Share by Type (2017-2021)

5.3.     SPECT (Hybrid SPECT, Standalone SPECT)

5.3.1.  Global SPECT (Hybrid SPECT, Standalone SPECT) Revenue and Growth Rate (2017-2021)

5.4.     Hybrid PET

5.4.1.  Global Hybrid PET Revenue and Growth Rate (2017-2021)

5.5.     Planar Scintigraphy

5.5.1.  Global Planar Scintigraphy Revenue and Growth Rate (2017-2021)

6.       Nuclear Imaging Devices  Market, By Applications

6.1.     Introduction

6.2.     Global Nuclear Imaging Devices  Revenue and Market Share by Applications (2017-2021)

6.2.1.  Global Nuclear Imaging Devices  Revenue and Revenue Share by Applications (2017-2021)

6.3.     Oncology

6.3.1.  Global Oncology Revenue and Growth Rate (2017-2021)

6.4.     Cardiology

6.4.1.  Global Cardiology Revenue and Growth Rate (2017-2021)

6.5.     Neurology

6.5.1.  Global Neurology Revenue and Growth Rate (2017-2021)

7.       Nuclear Imaging Devices  Market, By Region

7.1.     Introduction

7.2.     Global Nuclear Imaging Devices  Revenue and Market Share by Regions

7.2.1.  Global Nuclear Imaging Devices  Revenue by Regions (2017-2021)

7.3.     North America Nuclear Imaging Devices  by Countries

7.3.1.  North America Nuclear Imaging Devices  Revenue and Growth Rate (2017-2021)

7.3.2.  North America Nuclear Imaging Devices  Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1. United States Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1. Canada Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1. Mexico Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe Nuclear Imaging Devices  by Countries

7.4.1.  Europe Nuclear Imaging Devices  Revenue and Growth Rate (2017-2021)

7.4.2.  Europe Nuclear Imaging Devices  Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1. Germany Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1. France Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1. UK Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1. Russia Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1. Italy Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1. Rest of Europe Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific Nuclear Imaging Devices  by Countries

7.5.1.  Asia-Pacific Nuclear Imaging Devices  Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific Nuclear Imaging Devices  Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1. China Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1. Japan Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1. Korea Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1. India Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1. Southeast Asia Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1. Rest of Asia-Pacific Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America Nuclear Imaging Devices  by Countries

7.6.1.  South America Nuclear Imaging Devices  Revenue and Growth Rate (2017-2021)

7.6.2.  South America Nuclear Imaging Devices  Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1. Brazil Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1. Argentina Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1. Columbia Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1. Rest of South America Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa Nuclear Imaging Devices  by Countries

7.7.1.  Middle East and Africa Nuclear Imaging Devices  Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa Nuclear Imaging Devices  Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1. Saudi Arabia Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1. United Arab Emirates Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1. Egypt Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1. Nigeria Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1. South Africa Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1. Turkey Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1. Rest of Middle East and Africa Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     Siemens Healthineers (Germany)

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     GE Healthcare (US)

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Koninklijke Philips (Netherlands)

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Digirad Corporation (US)

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Neusoft Medical Systems Co., Ltd (US)

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Canon Medical Systems Corporation (Japan)

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     SurgicEye GmbH (Germany)

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     DDD-Diagnostic A/S (Denmark)

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     CMR Naviscan Corporation (US)

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Mediso Ltd. (Hungary)

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

8.11. Shimadzu Corporation (Japan)

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.      Financial Overview

9.       Nuclear Imaging Devices  Market Forecast (2022-2027)

9.1.     Global Nuclear Imaging Devices  Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     Nuclear Imaging Devices  Market Forecast by Regions (2022-2027)

9.2.1.  North America Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.1.1. United States Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.1.2. Canada Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.1.3. Mexico Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.2.  Europe Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.2.1. Germany Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.2.2. France Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.2.3. UK Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.2.4. Russia Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.2.5. Italy Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.2.6. Rest of Europe Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.3.  Asia-Pacific Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.3.1. China Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.3.2. Japan Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.3.3. Korea Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.3.4. India Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.3.5. Southeast Asia Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.3.6. Rest of Asia-Pacific Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.4.  South America Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.4.1. Brazil Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.4.2. Argentina Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.4.3. Columbia Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.4.4. Rest of South America Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.5.  Middle East and Africa Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.5.1. Saudi Arabia Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.5.2. United Arab Emirates Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.5.3. Egypt Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.5.4. Nigeria Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.5.5. South Africa Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.5.6. Turkey Nuclear Imaging Devices  Market Forecast (2022-2027)

9.2.5.7. Rest of Middle East and Africa Nuclear Imaging Devices  Market Forecast (2022-2027)

9.3.     Nuclear Imaging Devices  Market Forecast by Type (2022-2027)

9.3.1.  Nuclear Imaging Devices  Forecast by Type (2022-2027)

9.3.2.  Nuclear Imaging Devices  Market Share Forecast by Type (2022-2027)

9.4.     Nuclear Imaging Devices  Market Forecast by Applications (2022-2027)

9.4.1.  Nuclear Imaging Devices  Forecast by Applications (2022-2027)

9.4.2.  Nuclear Imaging Devices  Market Share Forecast by Applications (2022-2027)


List of Tables

List of Tables and Figures:

Figure United States Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Nuclear Imaging Devices Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Nuclear Imaging Devices Revenue and Revenue Share by Type (2017-2019)
Figure Global SPECT (Hybrid SPECT, Standalone SPECT) Revenue and Growth Rate (2017-2019)
Figure Global Hybrid PET Revenue and Growth Rate (2017-2019)
Figure Global Planar Scintigraphy Revenue and Growth Rate (2017-2019)
Table Global Nuclear Imaging Devices Revenue and Revenue Share by Applications (2017-2019)
Figure Global Oncology Revenue and Growth Rate (2017-2019)
Figure Global Cardiology Revenue and Growth Rate (2017-2019)
Figure Global Neurology Revenue and Growth Rate (2017-2019)
Table Global Nuclear Imaging Devices Revenue by Regions (2017-2019)
Figure North America Nuclear Imaging Devices Growth Rate (2017-2019)
Figure North America Nuclear Imaging Devices Revenue and Growth Rate (2017-2019)
Figure North America Nuclear Imaging Devices by Countries (2017-2019)
Figure North America Nuclear Imaging Devices Revenue (Million USD) by Countries (2017-2019)
Figure United States Nuclear Imaging Devices Growth Rate (2017-2019)
Figure United States Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Canada Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Mexico Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Europe Nuclear Imaging Devices Revenue and Growth Rate (2017-2019)
Figure Europe Nuclear Imaging Devices by Countries (2017-2019)
Figure Europe Nuclear Imaging Devices Revenue (Million USD) by Countries (2017-2019)
Figure Germany Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Germany Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Nuclear Imaging Devices Growth Rate (2017-2019)
Figure France Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Nuclear Imaging Devices Growth Rate (2017-2019)
Figure UK Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Russia Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Italy Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Rest of Europe Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Asia-Pacific Nuclear Imaging Devices Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Nuclear Imaging Devices by Countries (2017-2019)
Figure Asia-Pacific Nuclear Imaging Devices Revenue (Million USD) by Countries (2017-2019)
Figure China Nuclear Imaging Devices Growth Rate (2017-2019)
Figure China Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Japan Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Korea Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Nuclear Imaging Devices Growth Rate (2017-2019)
Figure India Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Southeast Asia Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Nuclear Imaging Devices Growth Rate (2017-2019)
Figure South America Nuclear Imaging Devices Revenue and Growth Rate (2017-2019)
Figure South America Nuclear Imaging Devices by Countries (2017-2019)
Figure South America Nuclear Imaging Devices Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Brazil Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Argentina Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Columbia Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Rest of South America Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Middle East and Africa Nuclear Imaging Devices Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Nuclear Imaging Devices by Countries (2017-2019)
Figure Middle East and Africa Nuclear Imaging Devices Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Saudi Arabia Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Nuclear Imaging Devices Growth Rate (2017-2019)
Figure United Arab Emirates Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Egypt Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Nigeria Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Nuclear Imaging Devices Growth Rate (2017-2019)
Figure South Africa Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Turkey Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Nuclear Imaging Devices Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2017-2019)
Table Siemens Healthineers (Germany) Nuclear Imaging Devices Financial Overview
Table GE Healthcare (US) Nuclear Imaging Devices Financial Overview
Table Koninklijke Philips (Netherlands) Nuclear Imaging Devices Financial Overview
Table Digirad Corporation (US) Nuclear Imaging Devices Financial Overview
Table Neusoft Medical Systems Co., Ltd (US) Nuclear Imaging Devices Financial Overview
Table Canon Medical Systems Corporation (Japan) Nuclear Imaging Devices Financial Overview
Table SurgicEye GmbH (Germany) Nuclear Imaging Devices Financial Overview
Table DDD-Diagnostic A/S (Denmark) Nuclear Imaging Devices Financial Overview
Table CMR Naviscan Corporation (US) Nuclear Imaging Devices Financial Overview
Table Mediso Ltd. (Hungary) Nuclear Imaging Devices Financial Overview
Table Shimadzu Corporation (Japan) Nuclear Imaging Devices Financial Overview
Figure Global Nuclear Imaging Devices Revenue (Millions USD) and Growth Rate (2019-2027)
Table Nuclear Imaging Devices Market Forecast by Regions (2019-2027)
Figure North America Nuclear Imaging Devices Market Forecast (2019-2027)
Figure United States Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Canada Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Mexico Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Europe Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Germany Nuclear Imaging Devices Market Forecast (2019-2027)
Figure France Nuclear Imaging Devices Market Forecast (2019-2027)
Figure UK Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Russia Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Italy Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Rest of Europe Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Asia-Pacific Nuclear Imaging Devices Market Forecast (2019-2027)
Figure China Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Japan Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Korea Nuclear Imaging Devices Market Forecast (2019-2027)
Figure India Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Southeast Asia Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Nuclear Imaging Devices Market Forecast (2019-2027)
Figure South America Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Brazil Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Argentina Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Columbia Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Rest of South America Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Middle East and Africa Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Saudi Arabia Nuclear Imaging Devices Market Forecast (2019-2027)
Figure United Arab Emirates Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Egypt Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Nigeria Nuclear Imaging Devices Market Forecast (2019-2027)
Figure South Africa Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Turkey Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Nuclear Imaging Devices Market Forecast (2019-2027)
Figure Global Nuclear Imaging Devices Forecast by Type (2019-2027)
Figure Global Nuclear Imaging Devices Market Share Forecast by Type (2019-2027)
Figure Global Nuclear Imaging Devices Forecast by Type (2019-2027)
Figure Global Nuclear Imaging Devices Forecast by Applications (2019-2027)
Figure Global Nuclear Imaging Devices Market Share Forecast by Applications (2019-2027)
Figure Global Nuclear Imaging Devices Forecast by Applications (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country